Healthcare has never been more innovative. It has also rarely been this complicated.
Across insurance and employer-supported healthcare, digital health has exploded.
AI powered triage, on demand mental health support, wearables and predictive analytics all promise to shift healthcare upstream – from treatment to prevention.
But there is an uncomfortable reality: outcomes are often not keeping pace with innovation. Healthcare costs remain a pressure point, claims patterns are changing, and clients and intermediaries increasingly tell us they feel overwhelmed by the volume of solutions.
The challenge for our industry has shifted. It is no longer about imagining what technology could do – but streamlining to make sure it genuinely delivers better care in the real world, across different healthcare systems and geographies.
The rise of ‘innovation theatre’
Not long ago, a strong digital proposition signalled innovation. Today, it’s simply expected.
Most schemes now come with an ecosystem of apps, services and platforms. On paper, this looks like progress.
In practice, customers are sharing their personal health data through a growing number of touchpoints, with journeys that can feel fragmented and unclear when support is needed most.
This is where the market risks slipping into “innovation theatre” – layering on more tools without materially improving the customer experience or clinical outcomes. The difficult question for insurers should no longer be ‘what we can add?’ but ‘what can we simplify or even remove?’
For the customer, healthcare is not experienced as a suite of products. It’s experienced as a moment of vulnerability – often urgent, sometimes confusing and increasingly digital-first.
Every additional log-in, platform or step between services has the potential to add friction at precisely the wrong time, especially for people navigating care across unfamiliar healthcare systems.
This is where the next phase of innovation is emerging. Not in new tools, but in better connected care.
A connected model reflects a broader reality: standalone digital services rarely change outcomes on their own. They only deliver value when they are embedded into clinically-led pathways and aligned across local and international provision.
In other words, access is easy to build. Continuity is much harder and far more valuable.
Prevention: ambition meets reality
Prevention has long been an ambition for healthcare, and something we’ve been striving for since I joined nearly 10 years ago.
What’s changed is that technology now gives us the tools to make it real at scale, across diverse populations with very different health risks.
Wearables and digital tools are bringing earlier signals. Genomics takes that a step further – identifying risk before symptoms even appear and enabling intervention much earlier in the pathway.
Genomics-led prevention pathways combine genetic risk, clinical assessment and digital triage to guide customers towards personalised interventions, from lifestyle support through to preventive treatment.
That shift starts to change the economics. Earlier engagement may increase activity in the short term, but it creates a clearer path to reducing severity and the cost of future claims in the long term.
As these models scale, prevention becomes less of a future ambition and more of a practical lever – improving outcomes, strengthening engagement and supporting more sustainable healthcare.
The hidden cost of complexity
If there is a single risk facing the market today, it is not under innovation – it is overcomplexity. What could be described as innovation inflation is quietly eroding both customer experience and economic efficiency.
Complexity drives duplication, duplication drives cost – all of which ultimately feeds back into affordability challenges for clients and customers.
The next generation of winners will not be those with the most partnerships or the longest feature lists. They will be those with the discipline to simplify – to strip back, integrate and focus on what genuinely matters to customers and improves outcomes.
That requires and shift in mindset. From showcasing innovation to curating it.
From high-tech to high impact
The future of healthcare will undoubtedly be more digital, more personalised and more predictive.
The differentiator will be the ability to make this technology work in the real world – consistently, at scale and in a way that customers actually use.
That means building models that are not just digitally enabled, but clinically grounded and economically sustainable. It means designing journeys, not products.
And it means recognising that innovation only has value when it delivers better outcomes, better experiences and sustainable costs. Anything else is just noise.
